Secretory phospholipase A2-IIa is a target gene of the HER/HER2-elicited pathway and a potential plasma biomarker for poor prognosis of prostate cancer

被引：0
|
作者：
Lu, Shan [1 ]
Oleksowicz, Leslie [1 ]
Liu, Yin [1 ]
Bracken, R. Bruce [1 ]
Gaitonde, Krishnanath [1 ]
Burke, Barbara [1 ]
Succop, Paul [1 ]
Levin, Linda [1 ]
Dong, Zhongyun [1 ]
机构：
[1] Univ Cincinnati, Coll Med, Cincinnati, OH USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-3631
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3631
引用
下载
收藏
页数：1
相关论文
共 39 条
  • [31] Myeloid differentiation factor-2/LY96, a potential predictive biomarker of metastasis and poor outcomes in prostate cancer: clinical implications as a potential therapeutic target
    Marina G. Ferrari
    Alexis P. Jimenez-Uribe
    Li Wang
    Luke H. Hoeppner
    Paari Murugan
    Eunsil Hahm
    Jindan Yu
    Timothy M. Kuzel
    Sergio A. Gradilone
    Adrian P. Mansini
    Oncogene, 2024, 43 : 484 - 494
  • [32] Gene expression profiling of prostate cancers from obese men identified HMGCS2 as a novel biomarker of aggressive prostate cancer and as a potential therapeutic target
    Freedland, SJ
    Darshan, M
    Wang, A
    Luo, J
    Demarzo, AM
    Dunn, T
    Fedor, H
    Mohan, I
    Mavropoulos, J
    Demark-Wahnefried, W
    Aronson, WJ
    Isaacs, WB
    JOURNAL OF UROLOGY, 2006, 175 (04): : 79 - 79
  • [33] c-erbB-2 (HER-2/neu) gene amplification is a better indicator of poor prognosis than protein over-expression in operable breast-cancer patients
    Riou, G
    Mathieu, MC
    Barrois, M
    Le Bihan, ML
    Ahomadegbe, JC
    Bénard, J
    Lê, MG
    INTERNATIONAL JOURNAL OF CANCER, 2001, 95 (04) : 266 - 270
  • [34] ABCB1 C3435T gene polymorphism as a potential biomarker of clinical outcomes in HER2-positive breast cancer patients
    Madrid-Paredes, Adela
    Canadas-Garre, Marisa
    Sanchez-Pozo, Antonio
    Maria Segura-Perez, Ana
    Chamorro-Santos, Clara
    Vergara-Alcaide, Esther
    Castillo-Portellano, Lucia
    Angel Calleja-Hernandez, Miguel
    PHARMACOLOGICAL RESEARCH, 2016, 108 : 111 - 118
  • [35] Bioinformatics and In Vitro Study Reveal ERα as The Potential Target Gene of Honokiol to Enhance Trastuzumab Sensitivity in HER2+Trastuzumab-Resistant Breast Cancer Cells
    Putra, I. Made Rhamanadana
    Lestari, Intan Ayu
    Fatimah, Nurul
    Hanif, Naufa
    Ujiantari, Navista Sri Octa
    Putri, Dyaningtyas Dewi Pamungkas
    Hermawan, Adam
    COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2024, 111
  • [36] Potential Role of HER2/Neu as a Molecular Target in the Treatment of High Grade Urothelial Cancer. Determination of Gene Amplification by FISH, CISH and IHC
    Aung, P. P.
    Walter, B. A.
    Garcia, C.
    Bratslavsky, G.
    Merino, M. J.
    LABORATORY INVESTIGATION, 2011, 91 : 179A - 179A
  • [37] Potential Role of HER2/Neu as a Molecular Target in the Treatment of High Grade Urothelial Cancer. Determination of Gene Amplification by FISH, CISH and IHC
    Aung, P. P.
    Walter, B. A.
    Garcia, C.
    Bratslavsky, G.
    Merino, M. J.
    MODERN PATHOLOGY, 2011, 24 : 179A - 179A
  • [38] From HER2/Neu signal cascade to androgen receptor and its coactivators: A novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells
    Yeh, SY
    Lin, HK
    Kang, HY
    Thin, TH
    Lin, MF
    Chang, CS
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (10) : 5458 - 5463
  • [39] Gene expression module associated with Insulin-like Growth Factor 1 (IGF1) pathway activation predicts poor response to tamoxifen in women with ER+/HER2-early breast cancer (BC).
    Ignatiadis, Michail
    Haibe-Keins, Benjamin
    Bedard, Philippe
    Singhal, Sandeep
    Lallemand, Francoise
    Desmedt, Christine
    Cardoso, Fatima
    Piccart, Marine
    Sotiriou, Christos
    CANCER RESEARCH, 2009, 69
1234